The agreement between IDF with WHO and NCEP-ATP III criteria was 0.37 (p < 0.001) and 0.53 (p < 0.001), respectively, whereas the agreement between NCEPATP
III and WHO criteria was 0.24 (p < 0.001).
The definition of MS according to the IDF criteria appears to be a better predictor of acute coronary syndrome than NCEPATP
III and NHLBI/AHA.
Modification of the NCEPATP
III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease.
For the individuals in TARA, the definition of metabolic syndrome developed by the National Cholesterol Education Program Adult Treatment Panel III (NCEPATP
III) results in a prevalence of 11%, a sensitivity of 21%, and a specificity of 97%.
The reported prevalence of MetS based on NCEPATP definition was within the range 3.75-25.6%.
The prevalence of MetS among Ghanaians was estimated to be in the range 6-21.2% based on three guidelines, NCEPATP, WHO, and IDF.
The overall prevalence of metabolic syndrome among the study population was 63.58%, 43.83%, and 69.14% using the World Health Organization (WHO), the National Cholesterol Education Program, Adult Treatment Panel III (NCEPATP
III), and the International Diabetes Federation (IDF) criteria, respectively.